Literature DB >> 16399567

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

Howard M Shulman1, David Kleiner, Stephanie J Lee, Thomas Morton, Steven Z Pavletic, Evan Farmer, J Margaret Moresi, Joel Greenson, Anne Janin, Paul J Martin, George McDonald, Mary E D Flowers, Maria Turner, Jane Atkinson, Jay Lefkowitch, M Kay Washington, Victor G Prieto, Stella K Kim, Zsolt Argenyi, A Hafeez Diwan, Asif Rashid, Kim Hiatt, Dan Couriel, Kirk Schultz, Sharon Hymes, Georgia B Vogelsang.   

Abstract

This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the management of hematopoietic cell transplantation patients. Optimal sampling and tissue preparation are discussed. Minimal criteria for the diagnosis of graft-versus-host disease (GVHD) are proposed, together with specific requirements for the diagnosis of chronic GVHD. Four final diagnostic categories (no GVHD, possible GVHD, consistent with GVHD, and definite GVHD) reflect the integration of histopathology with clinical, laboratory, and radiographic information. Finally, the Working Group developed a set of worksheets to facilitate communication of clinical information to the interpreting pathologist and to aid in clinicopathologic correlation studies. Forms are available at . The recommendations of the Working Group represent a consensus opinion supplemented by evaluation of available peer-reviewed literature. Consensus recommendations and suggested data-capture forms should be validated in prospective clinicopathologic studies.

Entities:  

Mesh:

Year:  2006        PMID: 16399567     DOI: 10.1016/j.bbmt.2005.10.023

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  112 in total

1.  Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  M Y Detrait; S Morisset; R Peffault de Latour; I Yakoub-Agha; R Crocchiolo; R Tabrizi; J-O Bay; P Chevalier; F Barraco; N Raus; S Vigouroux; L Magro; M Mohty; N Milpied; D Blaise; G Socié; M Michallet
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

Review 2.  [Histopathology of graft-versus-host disease].

Authors:  F Länger; F Puls; S Buchholz; C Loddenkemper; A Ganser; H Kreipe
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

Review 3.  Cutaneous graft-versus-host disease--clinical considerations and management.

Authors:  Peggy A Wu; Edward W Cowen
Journal:  Curr Probl Dermatol       Date:  2012-02-17

Review 4.  Prevention of graft-vs.-host disease.

Authors:  Andrew R Rezvani; Rainer F Storb
Journal:  Expert Opin Pharmacother       Date:  2012-07-07       Impact factor: 3.889

Review 5.  Graft-versus-host disease and immunosuppression.

Authors:  Neena Kapoor
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 6.  Fulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature review.

Authors:  Hidetaka Okubo; Naoyoshi Nagata; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

7.  International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.

Authors:  Andrew C Harris; Rachel Young; Steven Devine; William J Hogan; Francis Ayuk; Udomsak Bunworasate; Chantiya Chanswangphuwana; Yvonne A Efebera; Ernst Holler; Mark Litzow; Rainer Ordemann; Muna Qayed; Anne S Renteria; Ran Reshef; Matthias Wölfl; Yi-Bin Chen; Steven Goldstein; Madan Jagasia; Franco Locatelli; Stephan Mielke; David Porter; Tal Schechter; Zhanna Shekhovtsova; James L M Ferrara; John E Levine
Journal:  Biol Blood Marrow Transplant       Date:  2015-09-16       Impact factor: 5.742

Review 8.  Genetics of allogeneic hematopoietic cell transplantation. Role of HLA matching, functional variation in immune response genes.

Authors:  John A Hansen; Effie W Petersdorf; Ming-Tseh Lin; Steven Wang; Jason W Chien; Barry Storer; Paul J Martin
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 9.  Principles and overview of allogeneic hematopoietic stem cell transplantation.

Authors:  Sergio Giralt; Michael R Bishop
Journal:  Cancer Treat Res       Date:  2009

10.  Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency.

Authors:  Sung-Yun Pai; Ofer Levy; Haifa H Jabara; Jonathan N Glickman; Liat Stoler-Barak; Jessica Sachs; Samuel Nurko; Jordan S Orange; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.